BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33352047)

  • 21. Chemical probes that competitively and selectively inhibit Stat3 activation.
    Xu X; Kasembeli MM; Jiang X; Tweardy BJ; Tweardy DJ
    PLoS One; 2009; 4(3):e4783. PubMed ID: 19274102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors.
    Gao D; Jin N; Fu Y; Zhu Y; Wang Y; Wang T; Chen Y; Zhang M; Xiao Q; Huang M; Li Y
    Eur J Med Chem; 2021 Apr; 216():113333. PubMed ID: 33689932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells.
    Lin L; Deangelis S; Foust E; Fuchs J; Li C; Li PK; Schwartz EB; Lesinski GB; Benson D; Lü J; Hoyt D; Lin J
    Mol Cancer; 2010 Aug; 9():217. PubMed ID: 20712901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
    Gupta P; Srivastava SK
    BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
    Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
    J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer.
    Bharadwaj U; Eckols TK; Kolosov M; Kasembeli MM; Adam A; Torres D; Zhang X; Dobrolecki LE; Wei W; Lewis MT; Dave B; Chang JC; Landis MD; Creighton CJ; Mancini MA; Tweardy DJ
    Oncogene; 2015 Mar; 34(11):1341-53. PubMed ID: 24681959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas.
    Hutzen B; Friedman L; Sobo M; Lin L; Cen L; De Angelis S; Yamakoshi H; Shibata H; Iwabuchi Y; Lin J
    Int J Oncol; 2009 Oct; 35(4):867-72. PubMed ID: 19724924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3).
    Huang Q; Zhong Y; Li B; Ouyang S; Deng L; Mo J; Shi S; Lv N; Wu R; Liu P; Hu W; Zhang X; Wang Y
    Eur J Med Chem; 2021 Oct; 221():113525. PubMed ID: 34000483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
    Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of small molecule inhibitors of the STAT3 signaling pathway: Insights into their structural features and mode of action.
    Kim K; Kim SJ; Han YT; Hong SJ; An H; Chang DJ; Kim T; Lim B; Lee J; Surh YJ; Suh YG
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5444-8. PubMed ID: 26392052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT3 can be activated through paracrine signaling in breast epithelial cells.
    Lieblein JC; Ball S; Hutzen B; Sasser AK; Lin HJ; Huang TH; Hall BM; Lin J
    BMC Cancer; 2008 Oct; 8():302. PubMed ID: 18939993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylation.
    Zhao W; Zhang T; Qu B; Wu X; Zhu X; Meng F; Gu Y; Shu Y; Shen Y; Sun Y; Xu Q
    Anticancer Drugs; 2011 Jan; 22(1):79-88. PubMed ID: 20881478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
    Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J
    Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.
    Johnston PA; Sen M; Hua Y; Camarco D; Shun TY; Lazo JS; Grandis JR
    Assay Drug Dev Technol; 2014; 12(1):55-79. PubMed ID: 24127660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs.
    Butturini E; Carcereri de Prati A; Chiavegato G; Rigo A; Cavalieri E; Darra E; Mariotto S
    Free Radic Biol Med; 2013 Dec; 65():1322-1330. PubMed ID: 24095958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells.
    Zhao C; Wang W; Yu W; Jou D; Wang Y; Ma H; Xiao H; Qin H; Zhang C; Lü J; Li S; Li C; Lin J; Lin L
    Oncotarget; 2016 Mar; 7(11):12917-26. PubMed ID: 26883202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design.
    Yu W; Xiao H; Lin J; Li C
    J Med Chem; 2013 Jun; 56(11):4402-12. PubMed ID: 23651330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways.
    Lim EJ; Hong DY; Park JH; Joung YH; Darvin P; Kim SY; Na YM; Hwang TS; Ye SK; Moon ES; Cho BW; Do Park K; Lee HK; Park T; Yang YM
    PLoS One; 2012; 7(4):e33361. PubMed ID: 22485142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast Cancer.
    Ko H; Lee JH; Kim HS; Kim T; Han YT; Suh YG; Chun J; Kim YS; Ahn KS
    Biomolecules; 2019 May; 9(5):. PubMed ID: 31058868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological Inhibition of CDK8 in Triple-Negative Breast Cancer Cell Line MDA-MB-468 Increases E2F1 Protein, Induces Phosphorylation of STAT3 and Apoptosis.
    Spear JM; Lu Z; Russu WA
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33291686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.